Table 1.

Cohort Characteristics.

	Total (N = 22)
Sex
Female	8 (36.4%)
Male	14 (63.6%)
Age (years)
Mean (SD)	66.5 (11.2)
Race
African American	7 (31.8%)
Asian	1 (4.5%)
White	14 (63.6%)
History of non-neurological comorbidities
Smoking	10 (45.5%)
Chronic obstructive pulmonary disease	2 (9.1%)
Asthma	8 (36.4%)
Diabetes	9 (40.9%)
Hypertension	15 (68.2%)
Coronary artery disease	4 (18.2%)
Congestive heart failure	4 (18.2%)
Cancer	7 (31.8%)
Immunosuppressive disease	8 (36.4%)
History of neurological comorbidities	6 (27.3%)
Epilepsy	2 (9.1%)
Stroke	1 (4.5%)
Headache	1 (4.5%)
Traumatic brain injury	1 (4.5%)
Spinal stenosis	2 (9.1%)
COVID-19 specific characteristics
Fever	15 (68.2%)
Pneumonia	6 (27.3%)
Mechanical ventilation required	18 (81.8%)
Hydroxychloroquine given as treatment	16 (72.7%)